• Conference Coverage
    HFSA 22nd Annual Scientific Meeting
    Sept. 15-18, 2018
    Nashville, Tennessee

    Reach experts with insights into the latest research and treatments in heart failure.
  • Conference Coverage
    AANA 2018 Annual Congress
    Sept. 21-25, 2018
    Boston, MA

    Reach experts and thought leaders with insights into the latest technologies in the nurse anesthetist sector.
  • Conference Coverage
    Plastic Surgery
    The Meeting
    Sept. 30-Oct. 1, 2018
    Chicago, IL

    Reach global experts with insights into the latest best practices from the plastic surgery sector.
  • Conference Coverage
    ID Week 2018
    Oct. 3-7, 2018
    San Francisco, CA

    Generate insights by connecting with global healthcare experts specializing in infectious disease and epidemiology.
  • Conference Coverage
    ESMO 2018 Congress
    Oct. 19-23, 2018
    Munich, Germany

    Reach global experts with insights into the latest best practices from the medical oncology sector.
  • Conference Coverage
    AAO 2018
    Oct. 27-30, 2018
    Chicago, IL

    Generate insights by connecting with industry-leading healthcare experts specializing in ophthalmology.
  • Conference Coverage
    VIVA 2018
    Nov. 5-8, 2018
    Las Vegas, NV

    Connect with global healthcare experts across the vascular intervention and medicine spectrum while gaining key insights.
  • Conference Coverage
    60th ASH Annual
    Meeting & Exposition
    Dec. 1-4, 2018
    San Diego, CA
    Generate insights from the leading experts in malignant and non-malignant hematology.
SYNDICATED STUDIES
OUR JOURNAL
Products & Service
Custom Market Research
Custom Market Research
Using a collaborative approach with unmatched benefits. HRA utilizes the full strength and expertise of the MJH enterprise to the service of our clients in consultative custom market research.
Pulse Research
Pulse Research
The pulse program offers timely insights drawn from our panel of more than 20,000 healthcare professionals.
Strategic Syndicated Research
Strategic Syndicated Research
HRA leverages their expertise to publish new reports regularly in different therapeutic and industry areas that are affecting healthcare. These studies gather data on industry trends and evolutions, which provide a baseline from which to build a more in-depth study.
HealthAdvisor Panel
HealthAdvisor Panel
HealthAdvisor is a growing community of healthcare experts who share opinions and insights through participation in focus groups, one-on-one interviews, and online surveys.
Conference Research
Conference Research
HRA conducts qualitative and quantitative research at more than 90 conferences each year, including several "exclusive" events conducted by our large enterprise. HRA offers their clients rapid, front-line results by asking their target audience strategic questions across all phases of their product's life cycle.
Digital Landscape Analysis
Digital Landscape Analysis
With more than two billion people actively engaged in online conversations, social media has the power to - and has - change the face of governments, shaped policy, lifted and/or killed brands and reputations. HRA has deep experience in employing social media and other digital data points to set the stage for everything from data-driven creative used in marketing to competitive intelligence. HRA often uses digital landscape assessments around conference work to surface key themes and opinions about the latest research, drugs, protocols, or positions. Social also blends well with and guide qualitative and quantitative studies.
Webinars & Analytics
How will precision medicine impact the cardiovascular field? Listen into our interactive webinar to learn more.
Are outcome-based contracts the key to swift adoption of your pharmaceutical to formularies? HRA® investigated the payer perspective on whether these contacts will shift pharmaceutical spending to more effective drugs. Listen into our interactive webinar to learn more!
As therapies like Kymriah and Yescarta transform medicine, how can you assist in swift uptake of these treatments or ensure success in the development of yours? Listen into HRA®'s upcoming webinar to discuss the challenges and how to combat them.
An HRA® Publication
Is it OK for digital health tools to exclude vulnerable populations?
Leica Microsystems says the tech enables surgeons to make critical decisions when they matter most.
Technology and medicine aren't just crossing paths, they're converging. What does a happy medium look like?
The company touted its “trust and transparency” software services as a hammer to the black box of artificial intelligence.
FHIR could help health systems achieve interoperability.
Fitbit Care uses health coaching and personalized digital health interventions. It also provides health systems, insurers and employers with enterprise-level data.
Humana will hire as many as 250 people to staff an analytics center in Boston, but the company is still nailing down the details.
There are three significant challenges that health systems need to address to overcome the artificial intelligence adoption gap.
Apple's newest wearable has the potential to open new doors to yet unimagined ideas and concepts in healthcare. It also has the potential to freak people out for no good reason, and overburden physicians. 
Syndicated Studies
HRA® conducted a study to analyze the infectious disease landscape and scope for areas of opportunities for drug development, product marketing, and physician education. Use this syndicated study to strategically guide your entrance into this space and target infectious disease specialists.
Recent legislation has provided a faster path to market for biosimilars which are positioned to revolutionize the field of protein therapeutics. HRA® analyzed clinical, regulatory, and survey information on biosimilars to improve understanding and future expectations in the field. HRA® conducted an online survey with 160 Rheumatologists and Oncologists designed to yield insights into potential drivers of biosimilar prescribing. In addition, key insights from payers were included.
HRA® conducted a syndicated study to analyze the primary care physican (PCP) perceived involvement in cancer care. In this study, HRA® touched all facets of the relationship between PCPs and oncology from EMRs, early referrals and how to ensure both parties are informed to better the relationship between pharma, cancer centers,and PCPs.
Conferences
HRA is the premier provider of qualitative and quantitative research at healthcare conferences. HRA Rapid Results Conference offers clients the opportunity to get quick front line insights from their target audience from all phases of the product life cycle.
See where we'll be next year:
Full year conference calendar by therapeutic area
Full year conference calendar by month
About Us
Our People
HRA is not just another market intelligence firm. HRA is powered by the strength of the Michael J. Hennessy, Associates healthcare communications and education enterprise, which gives HRA a strong backbone in healthcare and a deep mastery to drive a unique perspective for our clients' market research needs.

HRA leverages a proprietary panel of nearly 20,000 healthcare professionals and the MJH enterprise database of healthcare professionals.
Client Support & Business Development
Research and Analytics
Operational Innovation
Our Network
Professionals
Pharmacists
Payers
Patients
Partners
At Michael J. Hennessy Associates, Inc. our team has established reputation for offering timely, relevant, and practical information that meets the needs of our diverse audience. We provide healthcare professionals with the information and resources they need to maintain patient well-being. As a full-service healthcare communications company, we provide integrated communication products and services, education and research to the healthcare industry.
Copyright HRA Data Driven Intelligence 1974-2018 HRA Data Driven Intelligence, LLC. All rights Reserved.
^